Skip to main navigation Skip to search Skip to main content

Candida haemulonii: An emerging opportunistic pathogen in the United States?

Research output: Contribution to journalArticlepeer-review

Abstract

Candida species are ubiquitous fungal pathogens that exhibit increasing resistance to anti-fungal agents. Candida haemulonii, a rare subtype, is an emerging and virulent yeast pathogen. Species identification is difficult due to phenotypic similarity to other Candida subtypes, such that there is a high risk of inappropriate antimicrobial administration and worsening of emerging resistance patterns. Candida haemulonii has a proclivity for infection of chronic lower extremity wounds particularly in diabetic patients, as exemplified in our case. This case raises awareness about the necessity for expeditious identification and antimicrobial stewardship directed to a highly resistant emerging pathogen.

Original languageEnglish (US)
Article numbere00900
JournalIDCases
Volume21
DOIs
StatePublished - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Candida haemulonii
  • Debridement
  • Diabetes
  • Osteomyelitis
  • Wound care

ASJC Scopus subject areas

  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Candida haemulonii: An emerging opportunistic pathogen in the United States?'. Together they form a unique fingerprint.

Cite this